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Direct killing of diseased cells is a hallmark function of NK cells. This protocol describes a flowbased assay to measure in vivo activated murine NK cells’ ability to kill target cells ex vivo.
Existing published protocols for assaying ex vivo NK cell killing utilized the radioactive chromium
release assay or were designed for human NK cells. This protocol details specifically an ex vivo
cytotoxicity assay using primary murine NK cells enriched from splenocytes that were activated in
vivo with poly(I:C).
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SUMMARY

Direct killing of diseased cells is a hallmark function of NK cells. This protocol describes a flow-based assay to measure in vivo activated murine NK cells’ ability to
kill target cells ex vivo. Existing published protocols for assaying ex vivo NK cell
killing utilized the radioactive chromium release assay or were designed for human NK cells. This protocol details specifically an ex vivo cytotoxicity assay using
primary murine NK cells enriched from splenocytes that were activated in vivo
with poly(I:C).
For complete details on the use and execution of this protocol, please refer to
Wagner et al. (2020).
BEFORE YOU BEGIN
Prepare murine IL-15 working stock from lyophilized powder
Timing: 10 min
This step describes the preparation of IL-15 stock from lyophilized powder. IL-15 will be used during
the killing assay to maintain NK cell viability.
1. Reconstitute 10 mg recombinant murine IL-15:
a. Add 100 mL sterile H2O to lyophilized powder and mix by pipetting
b. Add 900 mL sterile PBS + 0.1% w/v BSA(A7906) and mix by pipetting, so that the final concentration is 10 ng/mL
2. Divide into aliquots and store at 20 C to 80 C for up to 3 months. Avoid repeated freeze-thaw
cycles.
Culture RMA-S cell line
Timing: >2 days before killing assay
The target cell line to be used in this protocol should be thawed and cultured >2 days before the
killing assay.
Alternatives: RMA-S is the MHC-I-deficient target cell line used in this protocol, but any alternative NK-sensitive target cell line of choice can be used.
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Note: The RMA cell line can be used as a negative control for NK cell killing. Because RMA-S is
a well-established MHC-I-deficient target cell line for NK cell killing, killing assays against
RMA-S are commonly performed without comparison to RMA cells.
3. Thaw RMA-S cells
a. Warm 10 mL of cRPMI media in a 15-mL conical
b. Remove RMA-S frozen stock from liquid nitrogen tank
c. Place RMA-S cryovial in the 37 C water bath, and as soon as it is thawed, slowly transfer the
cells into the pre-warmed 10 mL cRPMI media
d. Centrifuge tube at 400 3 g, 4 min at 20 C–25 C
e. Resuspend in appropriate amount of media so that the concentration is between 2–5 3 105
cells/mL, transfer to a tissue culture flask
4. Maintain RMA-S in culture for up to 1 month; perform media change regularly to prevent overgrowth of the cells
Recommended: assess baseline Granzyme B expression
Timing: day before killing assay; 2 h plus flow analysis time
This step describes the assessment of baseline Granzyme B expression of NK cells harvested from
peripheral blood of the mice before activation.
5. Collect samples, prior to poly(I:C) administration
a. Perform cheek bleed on mice to collect blood into EDTA tubes
b. Transfer all blood volume into 15-mL conicals containing 4 mL 13 ACK lysis buffer
c. Lyse for 1 min, stop lysis by quantum statis (q.s.) to 15 mL, using DPBS
d. Centrifuge the tubes at 400 3 g, 4 min at 20 C–25 C, aspirate supernatant
e. Lyse cells again with 4 mL 13 ACK lysis buffer for 1 min, q.s. to 15 mL with DPBS
f. Centrifuge tubes at 400 3 g , 4 min at 20 C–25 C, aspirate supernatant
g. Resuspend cells in 250 mL FACS buffer and transfer through a 70 mm filter into a 96-well for
staining
6. Stain cells for baseline Granzyme B expression before activation
a. Prepare surface stain master mix:

Surface stain master mix
Amount per well
anti-NKp46 PE

2 mL

anti-NK1.1 PerCPCy5.5

4 mL

anti-CD3 PB

1 mL

anti-CD45 BV605

1 mL

Fc Block

1 mL

FACS buffer

91 mL

Total:

100 mL

b.
c.
d.
e.

2

Add 100 mL surface stain master mix to each well
Incubate for 15 min at 4 C in the dark
After the incubation, centrifuge at 400 3 g, 4 min at 20 C–25 C, tap out supernatant
Wash the plate twice with 200 mL FACS buffer
i. Add FACS buffer, centrifuge at 400 3 g, 4 min at 20 C–25 C, tap out supernatant. Repeat
once more.
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Make up 200 mL of eBioSciences Fixation/Permeabilization(Fix/Perm) solution per well
following manufacturer’s instructions (1 part Concentrate : 3 part Diluent)
Resuspend each well in 200 mL eBioSciences Fix/Perm Solution
Incubate at 4 C for 30 min up to 18 h
Centrifuge plate at 750 3 g, 4 min at 4 C, tap out supernatant
Prepare 13 Permeabilization Buffer by diluting 103 Permeabilization buffer in water, according to manufacturer’s instructions
Add 200 mL 13 Permeabilization Buffer to each well, mix
Centrifuge plate at 750 3 g, 4 min at 4 C, tap out supernatant
Make up Granzyme B master mix:

Granzyme B master mix
Amount per well
anti-Granzyme B APC

2 mL

Goat serum

1 mL

13 Permeabilization Buffer

97 mL

Total:

100 mL

n. Add 100 mL of Granzyme B master mix to each well, mix
o. Incubate for 30 min at 4 C in the dark
p. Wash plate twice with 13 Permeabilization Buffer
i. Add 13 Permeabilization Buffer, centrifuge at 750 3 g, 4 min at 4 C. Tap out supernatant.
Repeat once more.
q. Resuspend in 200 mL FACS buffer and analyze on the flow cytometer

KEY RESOURCES TABLE

REAGENT or RESOURCE

SOURCE

IDENTIFIER

APC Granzyme B anti-human mAb (GB12)

Thermo Fisher

Cat# MHGB05

PE-Cyanine7 NKp46 anti-mouse mAb (29A1.4)

Thermo Fisher

Cat# 25-3351-82

PerCP-Cy5.5 anti-mouse NK-1.1 mAb (PK136)

BD Biosciences

Cat# 561111

Brilliant Violet 605 anti-mouse CD45 mAb (30-F11)

BioLegend

Cat# 103139

Pacific Blue anti-mouse CD3e(500A2)

BD Pharminogen

Cat#558214

Mouse BD Fc Block

BD Bioscience

Cat# 553142

Goat serum (heat-inactivated)

Sigma-Aldrich

Cat#9023

HyClone classical liquid media: RPMI 1640

Thermo Fisher

Cat# SH30027LS

Fetal bovine serum

Sigma-Aldrich

Cat# F0926

Antibodies

Chemicals, peptides, and recombinant proteins

Cytofix/Cytoperm fixation and permeabilization solution

BD Bioscience

Cat# BDB554722

Murine IL-15

Peprotech

Cat#210-15

Poly(I:C) LMW

Invivogen

Cat#tlrl-picw

7-AAD

Sigma-Aldrich

Cat#A9400

Hyclone L-glutamine

Thermo Fisher

Cat# SH3003402

Hyclone HEPES solution

Thermo Fisher

Cat# SH3023701

HyClone non-essential amino acids

Thermo Fisher

Cat# SH3023801

HyClone sodium pyruvate solution

Thermo Fisher

Cat# SH3023901

HyClone penicillin streptomycin 1003 solution

Thermo Fisher

Cat# SV30010

Potassium bicarbonate

Fisher Scientific

Cat#235-500

0.5 M EDTA solution

Corning

Cat#46-034-Cl
(Continued on next page)
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Continued
REAGENT or RESOURCE

SOURCE

IDENTIFIER

Ammonium chloride

Sigma

Cat# A9434

HyClone DPBS (calcium, magnesium)

GE

Cat# SH09928.03

2-Mercaptoethanol (2-ME)

Life Technologies

Cat# 21985-023

CellTrace Violet Cell Proliferation Kit
EasySep Mouse NK Cell Isolation Kit

Thermo Fisher
STEMCELL Technologies

Cat# C34557
Catalog # 19855

eBioscience fixation/permeabilization Concentrate
eBioscience Fixation/Permeabilization diluent

Invitrogen
Invitrogen

Cat# 00-5123-43
Cat# 00-5223-56

Permeabilization buffer (103)

Invitrogen

Cat#00-8333-56

ATCC

RRID:CVCL_2180

N/A

N/A

Biosafety cabinet
Cell culture incubator

N/A
N/A

N/A
N/A

Dissection tools
Beckman Coulter Allegra X-15R centrifuge (or similar)

N/A
N/A

N/A
N/A

Beckman Coulter Gallios flow cytometer (or similar)
Nexcelom cellometer (or similar)

N/A
N/A

N/A
N/A

Critical commercial assays

Experimental models: cell lines
Mouse: RMA-S
Experimental models: organisms/strains
Mice (8–12 weeks old) to serve as your source of NK cells
(2–3 mice per group will be pooled together)
Other

EasySep magnet

STEMCELL Technologies

Cat#18000

1 L/500 mL 0.22 mm filter
70 mm cell filter

Fisher
Fisher

REF# 09-761-107
REF#352350

100 mm 3 15 mm Petri dish or similar
Insulin syringe or similar

N/A
N/A

N/A
N/A

15-mL conical tubes
T-75 cell culture flasks

N/A
N/A

N/A
N/A

96-well staining plate
3 mL syringe

Fisher
BD

REF#3365
REF#309657

5 mL polypropylene round-bottom tube
96-well cell culture plate, V-bottom with lid

Fisher
Fisher

REF#352063
REF#3894

MATERIALS AND EQUIPMENT

Media and buffer
Complete RPMI (cRPMI) media
Reagent

Amount

Final concentration

RPMI 1640 medium

430 mL

–

Heat-inactivated FBS

50 mL

10%

1003 Penicillin/streptomycin

5 mL

1%

Non-essential amino acids

5 mL

1%

Sodium pyruvate

5 mL

1%

L-Glutamine

5 mL

1%

Total volume

500 mL

–

Set up 0.22 mm filter, pour 200 mL of RPMI into filter, then add in the rest of the reagents, finish by
adding the remaining RPMI medium. Filter after all reagents are added. Store at 4 C for up to
1 month.

4
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FACS buffer
Reagent

Amount

Final concentration

DPBS

489 mL

–

Heat-inactivated FBS

10 mL

2%

0.5 M EDTA

1 mL

1 mM

Total volume

500 mL

–

Set up 0.22 mm filter, pour 300 mL of DPBS into filter, then add in the rest of the reagents, finish by
adding the remaining DPBS. Filter after all reagents are added. Store at 4 C for up to 3 months.

103 ACK Lysis buffer
Reagent

Amount

Ammonium chloride

80.24 g

Final concentration
1.5 M

Potassium bicarbonate

10.01 g

0.1 M

0.5 M EDTA solution

2 mL

1 mM

DPBS

to 1 L

–

Total volume

1L

1L

Filter through 0.22 mm filter after all reagents are added. Store at 4 C. To prepare 13 ACK Lysis
buffer, dilute 103 ACK Lysis buffer in sterile H2O. Store 13 ACK Lysis buffer at 20 C–25 C for up
to 6 months.

STEP-BY-STEP METHOD DETAILS
Activate NK cells
Timing: 18–24 h before killing assay, after obtaining pre-poly(I:C) blood samples
(optional); 30 min
This step uses poly(I:C) to activate NK cells in vivo.
1. For each mouse prepare 300 mg poly(I:C) in DPBS, 200 mL total volume
2. Inject poly(I:C) intraperitoneally, using an insulin syringe, into each mouse
Enrich NK cells from splenocytes
Timing: 1.5 h
The enrichment step not only serves to increase the percentage of NK cells in the resulting enriched
sample but also normalize the NK cell percentages in experimental groups that could have started
with different NK cell numbers. In our experience, the purity after enrichment is similar between
groups in each experiment even if they had different NK cell percentages to start as we did in Wagner et al. (2020).
Note: All of the following steps should be performed in a tissue culture hood to ensure sterility
3. Sacrifice mice and isolate splenocytes
a. Isolate spleen from mice, pooling spleens from every 2–3 mice to ensure sufficient NK cell
numbers for the killing assay
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Figure 1. Dissociation of spleens through filter using a 3-mL syringe plunger

Note: We recommend placing the isolated spleens in 1.5 mL cRPMI media and on ice while
waiting to be processed.
Note: We recommend performing steps (b)–(f) one group of pooled spleen at a time. Then
proceed to step (g) once all the spleens are ready.
b. Place spleens onto a 70 mm cell filter placed into a petri dish (Figure 1)
c. Add 2 mL of 1X ACK lysis buffer directly onto the spleens on the filter (Figure 1)
d. Using a 3-mL syringe plunger, crush spleens through the filter (Figure 1)
e. Transfer all volume into a 15-mL conical
f. Rinse petri dish with 13 mL DPBS and transfer into the same 15-mL conical
g. Centrifuge cells at 400 3 g, 4 min, 20 C–25 C, aspirate supernatant
h. Resuspend cells in 500 mL sterile FACS buffer
Note: To make sterile FACS buffer, filter FACS buffer through a 0.22 mm filter. Keep at 4 C
and open only in sterile tissue culture hoods.
i. Count live cells with AOPI on the cellometer
4. Enrich for NK cells using the STEM CELL TECHNOLOGIES NK EasySep purification kit
Note: this is a slightly modified version of the official manufacturer’s protocol (https://cdn.
stemcell.com/media/files/pis/28043-PIS_1_0_4.pdf?_ga=2.67415057.1840857299.16079594441584491980.1604954550). Here we perform the isolation cocktail and RapidSpheres incubation
steps in the same 15-mL conicals that the cells were resuspended in step 3h to minimize cell
loss and to incubate all cells from the same sample in the same tube. We transfer the sample to
5-mL tubes after these incubation steps while the manufacturer’s protocol recommends this to
be done in 5-mL tubes from the start.
a. Using cell counts from 3i, bring cells to the concentration of 1 3 108 cells/mL in the 15-mL
conical in sterile FACS buffer
Note: If the cell count indicates the concentration is less than 1 3 108 cells/mL, proceed with
the 500 mL of samples as that is the recommended minimum volume for the kit.
b. Add 50 mL of Isolation Cocktail (from kit) per mL of sample, pipette up and down to mix
c. Incubate at 20 C–25 C for 10 min

6
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Vortex RapidSpheres for 30 s to disperse the particles thoroughly
Add 100 mL of RapidSpheres per mL of sample. Pipette up and down to mix
Incubate at 20 C–25 C for 5 min
If the sample volume is greater than 2 mL at this point, divide into 2 tubes, so that each tube
has not more than 2 mL of samples
Q.S. to 2.5 mL with sterile FACS buffer
Mix by gently pipetting then carefully transfer the whole 2.5 mL into a 5-mL polypropylene
tube
Plate the tube without lid into the magnet, and incubate at 20 C–25 C for 5 min
Carefully pick up the magnet with the tube inside it, then invert the magnet, and tube to
decant the enriched cells into a new 15-mL conical tube
Remove the 5-mL polypropylene tube from the magnet, q.s. to 2.5 mL with sterile FACS buffer
and mix
Plate the tube back into the magnet again, and incubate at 20 C–25 C for 5 min
Carefully pick up the magnet with the tube sitting inside it, then invert the magnet and tube to
decant the enriched cells into the same 15-mL conical as step (k). Immediately proceed to ‘‘Set
Up Killing Assay’’ step.

Note: NK cell purity post-enrichment ranges from 50%–80% and will be assessed in the
Granzyme B activation panel (‘‘Assess NK cell Activation’’ step).
Alternatives: NK enrichment can be omitted so that the killing assay is performed with unenriched splenocytes as effectors, though the effector:target ratios for the killing assay would
have to be adjusted as noted in step 6d (Berrien-Elliott et al. 2019). If using unenriched splenocytes for effectors, after step 3g, proceed to step 6b.
Set up killing assay
Timing: 1 h setup; 4–6 h incubation; variable flow time
This step describes the preparation and plating of effector and target cells for the killing assay and
the assessment of killing on the flow cytometer after a 4–6 h incubation.
5. Prepare complete NK media:

Complete NK media
Reagent

Amount

cRPMI media

To 40 mL

Final concentration
–

1,0003 2-ME

40 mL

55 mM

10 ng/mL mIL-15

40 mL

10 ng/mL

CRITICAL: This media should be prepared fresh every time.
6. Prepare enriched NK cells
a. Centrifuge enriched cells at 400 3 g, 4 min at 20 C–25 C
b. Resuspend in 300–500 mL complete NK media
c. Count live cells and bring concentration to 2 3 106 cells/mL
Note: This assay as written would require around 4 3 105 cells total, which includes some extra
to assess purity and activation in ‘‘Assess NK Cell Activation’’ step. If not enough cells, this

STAR Protocols 2, 100262, March 19, 2021

7

ll

OPEN ACCESS

Figure 2. Example killing assay plating scheme
T only, target cells only.

assay can be scaled down accordingly. We have had great success with half the number of effectors and target cells scaled down accordingly. In such cases where we scaled down the
numbers of cell, we kept the volume of each well the same as described here.
d. Label a V-bottom 96-well plate for assay (Figure 2 for example)
e. Plate appropriate number of enriched NK cells for each effector to target ratio and bring volume of each well up to 100 mL:
For 5:1 wells (5 enriched NK: 1 Target) / 100 mL of enriched NK cells (2 3 105 enriched NK cells)
For 2:1 wells / 40 mL enriched NK cells (8 3 104 enriched NK cells) + 60 mL complete NK media
For 1:1 wells / 20 mL enriched NKcells (4 3 104 enriched NK cells) + 80 mL complete NK media
For 0.5:1 wells / 10 mL enriched NK cells (2 3 104 enriched NK cells) + 90 mL complete NK
media
Note: Make sure to include a well with Target Cells only and single-color control wells.
Alternatives: If using unenriched splenocytes as effectors, the effector to target ratios
commonly used are 100:1, 50:1, 25:1, and 12.5:1 (Berrien-Elliott et al. 2019). The concentration to resuspend the effector cells prior to plating (step 6c) would have to be adjusted
accordingly.
f. Place plate into 37 C incubator until target cells are prepared
g. Reserve and keep left over NK cells on ice for staining in ‘‘Assess NK Cell Activation’’ step to
assess NK cell activation and purity
7. Prepare Target Cells
a. Remove some RMA-S from culture flask and count live cells
b. Transfer 5 3 106 cells into a 15-mL conical and q.s. to 15 mL with DPBS
c. Centrifuge cells at 400 3 g, 4 min at 20 C–25 C, and aspirate supernatant
d. Wash cells once more with 5 mL DPBS; centrifuge cells at 400 3 g, 4 min at 20 C–25 C, and
aspirate supernatant
e. Make up 10 mM CellTrace Violet(CTV) working solution:

8

STAR Protocols 2, 100262, March 19, 2021

Protocol

ll

Protocol

f.
g.
h.
i.
j.
k.
l.
m.
n.
o.

OPEN ACCESS

i. Reconstitute stock CTV in 20 mL DMSO per manufacturer instructions (5 mM after reconstitution)
ii. 10 mM CellTrace Violet: 2 mL of 5 mM CTV stock in 1 mL DPBS total
Resuspend target cell pellet in 1 mL DPBS and then add 1 mL of 10 mM CTV, pipet up and
down to mix
Incubate for 15 min in 37 C incubator
After incubation add 10 mL warm cRPMI media into the tube then incubate 5 more minutes in
37 C incubator
Centrifuge at 400 3 g, 4 min at 20 C–25 C
Resuspend cells in 1 mL complete NK media
Count live cells and dilute cells to 4 3 105 cells /mL
Plate 100 mL target cells into each well (40,000 target cells per well)
i. At this point, each well should have 200 mL total volume
Gather cells at the bottom of the well by letting centrifuge to get up to 200 3 g, then stopping the centrifuge
Incubate for 4 h (up to 6 h) in 37 C incubator
At the end of the incubation, make up 7-AAD master mix:

7-AAD master mix
Amount per well
1 mg/mL 7-AAD

0.4 mL

FACS Buffer

9.6 mL

Total:

10 mL

p. Add 10 mL of 7-AAD master mix into each well, mix by pipetting, and transfer into flow tubes
q. Incubate at 20 C–25 C for 5 min, and analyze on flow cytometer immediately
Note: It is best to flow 7-AAD stained samples within an hour. If working with large number
of wells that will take longer than an hour to finish analyzing the whole plate on the flow cytometer, divide samples into groups, and add 7-AAD to each group immediately before
analyzing on the flow cytometry; keep the other groups at 4 C until ready for 7-AAD to
be added.
Note: When setting up voltages on the flow cytometer, use the CTV single color control to
make sure the voltage for the CTV channel is set appropriately so that the CTV+ cells are
clearly visible.
Note: The flow cytometry approach of this protocol allows for the inclusion of markers like Annexin V to further identify early apoptotic cells from dead cells. If that is of interest, we suggest
spinning down the assay plate after the incubation and perform 7-AAD/Annexin V staining in a
buffer suitable for Annexin V staining instead of the FACS buffer.
Assess NK cell activation
Timing: 2 h plus flow time; this staining can be performed during the 4 h killing assay
incubation
This step assesses whether the NK cells have been activated and NK-enriched samples’ purity. This
will provide a context in which the data from the killing assay will be interpreted.
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To ensure NK cells are incubated with target cells as soon as possible after they have been harvested
from the mice, we perform this step after the killing assay is set up.
8. Stain enriched NK cells for activation and purity
a. Plate left over enriched NK cells in to a 96-well staining plate, no more than 1–2 3 106 cells per
well; 30,000 cells minimum if possible
b. Centrifuge plate at 400 3 g, 4 min at 20 C–25 C, tap out supernatant
c. Prepare surface stain master mix:

Surface stain master mix
Reagent

Amount per well (mL)

anti-NKp46 PE

2

anti-NK1.1 PerCPCy5.5

4

anti-CD3 PB

1

anti-CD45 BV605

1

Fc Block

1

FACS buffer

91

Total:

100

Add 100 mL surface stain master mix to each well, mix
Incubate for 15 min at 4 degrees in the dark
After the incubation, centrifuge at 400 3 g, 4 min at 20 C–25 C, tap out supernatant
Wash the plate twice with 200 mL FACS buffer
i. Add FACS buffer, mix, and centrifuge at 400 3 g, 4 min at 20–25 C. Tap out supernatant,
repeat once more.
h. Resuspend each well in 200 mL eBioScience Fix/Perm Solution, mix

d.
e.
f.
g.

Alternatives: We have also performed fix/perm and Granzyme B staining using the BD
fix/perm kit (Cat#554714) with success. Please follow the BD kit instructions from step 8h
onwards if using it instead of the eBioScience kit described here.
i. Incubate at 4 C for 30 min up to 18 h
j. Centrifuge plate at 750 3 g, 4 min at 4 C, tap out supernatant
k. Prepare 13 Permeabilization Buffer by diluting 103 Permeabilization buffer in water
l. Add 200 mL 13 Permeabilization to each well, mix
m. Centrifuge plate at 750 3 g, 4 min at 4 C, tap out supernatant
n. Make up Granzyme B master mix:

Granzyme B master mix
Amount per well (mL)
anti-Granzyme B APC

2

Goat Serum

1

13 Permeabilization Buffer

97

Total:

100

o. Add 100 mL of Granzyme B master mix to each well, mix
p. Incubate for 30 min at 4 C in the dark
q. Wash plate twice with 13 Permeabilization Buffer
i. Add 13 Permeabilization Buffer, centrifuge at 750 3 g, 4 min at 4 C. Tap out supernatant.
Repeat once more.
r. Resuspend in 200 mL FACS buffer and analyze on the flow cytometer

10
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Figure 3. Example killing assay data
(A) Example gating strategy for assessment of target cell killed by effectors. Data acquired on the Beckman Coulter Gallios flow cytometer and analyzed
on Flowjo 10.
(B) Example data of killing assay performed with wild-type enriched NK cells against RMA-S targets at indicated effector:target ratio (n = 2–3). Data are
presented as means G SEM.

EXPECTED OUTCOMES
At the end of the 4-h incubation, when analyzed on flow cytometer, cells that are double positive for
CTV and 7-AAD are the labeled-target cells that have been killed (Figure 3A). For each E:T ratio,
Percent Specific Killing is calculated as [% 7-AAD+ of CTV+ cells] (Effector+Target) well – [%7-AAD+ of
CTV+ cells] Target only well . In a killing assay performed C57BL/6 mice with wild-type NK cells against
RMA-S targets, the %specific killing should be around 50% at 5:1 enriched NK : RMA-S as reported in
Wagner et al. (2020) and also Figure 3B here. In vivo poly(I:C) activation should result R 90% of NK
cells expressing Granzyme B (Figure 4).

LIMITATIONS
This protocol is optimized to examine short-term killing within a 4-h time frame, when the granyzme
B/perforin mediated killing pathway dominates (Prager et al. 2019). If studying cytotoxicity mediated by death-ligand interaction is of interest, an alternative strategy is to perform prolonged killing
assays and/or use alternative methods, instead of the flow cytometry, such as the Incucyte to monitor
killing overtime.
Because this protocol requires pooling spleens from multiple mice, individual mouse to mouse differences are not captured. Therefore, if performing studies where collecting data from each individual mouse is critical, we suggest scaling down the number of cells used in the killing assay or only
perform one E:T ratio to accommodate for lower cell numbers. Alternatively, NK enrichment can
be omitted, and this protocol can be performed with unenriched splenocytes instead.
NK cell percentage post-enrichment using the STEMCELL TECHNOLOGIES NK isolation kit as
described in this protocol ranges from 50%–80% in our experience, and we have been able to consistently achieve killing of RMA-S targets with this range of NK percentage in the samples. To our
knowledge, there are no commercially available beads-based selection product that can achieve
better purity. If >80% NK purity is desired, sorting by FACS, a much less accessible approach, will
be required.
If working with precious mouse strains with limited numbers where the number of different analyses
performed on each mouse needs to be maximized, systemic in vivo activation with poly(I:C) may not
be ideal, as this precludes opportunities to study the mice at homeostasis. In such cases, one may
choose to activate NK cells in vitro by incubating them with IL-15 for 18–24 h in complete NK media
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Figure 4. Example gating strategy for Granzyme B activation assessment on post-poly(I:C) enriched NK cell compared to pre-poly(I:C) baseline
sample from cheek bleed
Data acquired on the Beckman Coulter Gallios flow cytometer and analyzed on Flowjo 10.

instead and then performing the killing assay described. However, such method may not reflect the
in vivo NK biology as closely as activating in vivo and performing the killing assay directly ex vivo as
described here.

TROUBLESHOOTING
Problem 1
Insufficient numbers of enriched NK cells (step 4)
Potential solution
Solution 1: Pool spleens from more mice
Solution 2: Scale down the assay to use fewer cells. We have had great success with using half the
number of enriched NK cells (with the target cell numbers scaled down accordingly for each effector:target ratio).
Solution 3: Perform assay with fewer E:T ratios. Instead of doing all 4 ratios listed above, pick only 1
or 2 that you have sufficient amount of cells to perform.
Problem 2
CellTrace reagent signal too high on flow cytometer (step 8r)
Potential solution
Solution 1: Use CellTrace labeled single color control cells to set the voltage appropriately before
running samples
Solution 2: Dilute CellTrace reagent to be less concentrated when labeling cells
Problem 3
Florescent reporter protein expressed by the cells cannot be detected when staining with the
eBioscience Fix/Perm kit (step 8h)
Potential solution
Solution 1: Use BD Cytofix/Cytoperm Fixation/Permeablization Kit (BD Biosciences Cat# 554714)
instead, following the manufacturer’s instructions for intracellular staining
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Solution 2: After surface staining, wash once with FACS buffer, then pre-fix cells with 1% PFA for
2 min at 20 C–25 C, immediately centrifuge cells and tap out PFA, then proceed with eBio Fix/
Perm protocol.

RESOURCE AVAILABILITY
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Materials availability
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This study did not generate datasets or codes.
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